Announcements Trials

Browse Landscape

Status

Completed 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 13 Lymphoid 9 CNS 7 Other hematologic neoplasm 6 Gastrointestinal 6 Head & Neck 4 Breast 4 Other solid neoplasm 2 Thoracic 1 Sarcoma 1 Other neoplasm 1 Myeloid 1 Gynecologic 1 Dermatologic 1

Conditions

Hemangiosarcoma 1

Interventions

Doxorubicin 25 Cyclophosphamide 24 pembrolizumab 20 Specimen Handling 19 Temozolomide 16 Magnetic Resonance Spectroscopy 15 Surgical Procedures, Operative 14 Radiotherapy 13 Blood Specimen Collection 13 Biopsy 13 atezolizumab 12 Gemcitabine 12 fludarabine 11 Vincristine 11 Ifosfamide 11 X-Rays 8 Trabectedin 8 Nivolumab 8 Irinotecan 8 Imatinib Mesylate 8 Drug Therapy 8 cabozantinib 7 Surveys and Questionnaires 7 Radiation 7 liposomal doxorubicin 5 abemaciclib 5 Sunitinib 5 Standard of Care 5 Radiation Dose Hypofractionation 5 Dactinomycin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Watchful Waiting × Sarcoma × Clear all

NCT06375941 2025-11-20

ProStars

Italian Sarcoma Group

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡